PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 69.32% | 107.27% | 7.37% | 47.75% | 48.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.32% | 107.27% | 7.37% | 47.75% | 48.14% |
| Cost of Revenue | 69.50% | 114.96% | 8.17% | 48.04% | 56.28% |
| Gross Profit | 68.74% | 84.28% | 5.20% | 46.84% | 28.05% |
| SG&A Expenses | 63.93% | 79.91% | 46.85% | 74.41% | 118.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.16% | 108.01% | 17.44% | 53.11% | 65.29% |
| Operating Income | 71.54% | 94.73% | -166.38% | -17.74% | -40.48% |
| Income Before Tax | 97.98% | 102.36% | -181.32% | -24.02% | -49.72% |
| Income Tax Expenses | 632.57% | 22.69% | -223.98% | -22.78% | -83.77% |
| Earnings from Continuing Operations | 44.00% | 152.51% | -153.59% | -24.46% | -36.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.00% | 152.51% | -153.59% | -24.46% | -36.21% |
| EBIT | 71.54% | 94.73% | -166.38% | -17.74% | -40.48% |
| EBITDA | 103.00% | 103.88% | -99.29% | -11.27% | -40.61% |
| EPS Basic | 43.98% | 153.21% | -153.45% | -24.75% | -36.09% |
| Normalized Basic EPS | 73.74% | 105.66% | -166.29% | -24.28% | -39.32% |
| EPS Diluted | 43.98% | 153.21% | -153.45% | -24.75% | -36.09% |
| Normalized Diluted EPS | 73.74% | 105.66% | -166.29% | -24.28% | -39.32% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |